These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16842970

  • 1. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines.
    Sharrard RM, Maitland NJ.
    Cell Signal; 2007 Jan; 19(1):129-38. PubMed ID: 16842970
    [Abstract] [Full Text] [Related]

  • 2. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
    Rodríguez-Escudero I, Roelants FM, Thorner J, Nombela C, Molina M, Cid VJ.
    Biochem J; 2005 Sep 01; 390(Pt 2):613-23. PubMed ID: 15913452
    [Abstract] [Full Text] [Related]

  • 3. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW, Wright KL, Burgess SJ, Astoul E, Cantrell DA, Ward SG.
    J Immunol; 2002 Nov 15; 169(10):5441-50. PubMed ID: 12421919
    [Abstract] [Full Text] [Related]

  • 4. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
    Mokhtari D, Al-Amin A, Turpaev K, Li T, Idevall-Hagren O, Li J, Wuttke A, Fred RG, Ravassard P, Scharfmann R, Tengholm A, Welsh N.
    Diabetologia; 2013 Jun 15; 56(6):1327-38. PubMed ID: 23462796
    [Abstract] [Full Text] [Related]

  • 5. SHIP2 inhibition alters redox-induced PI3K/AKT and MAP kinase pathways via PTEN over-activation in cervical cancer cells.
    Azzi A.
    FEBS Open Bio; 2020 Oct 15; 10(10):2191-2205. PubMed ID: 32881386
    [Abstract] [Full Text] [Related]

  • 6. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
    Mandl A, Sarkes D, Carricaburu V, Jung V, Rameh L.
    Mol Cell Biol; 2007 Dec 15; 27(23):8098-112. PubMed ID: 17893321
    [Abstract] [Full Text] [Related]

  • 7. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.
    Taylor V, Wong M, Brandts C, Reilly L, Dean NM, Cowsert LM, Moodie S, Stokoe D.
    Mol Cell Biol; 2000 Sep 15; 20(18):6860-71. PubMed ID: 10958682
    [Abstract] [Full Text] [Related]

  • 8. Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
    Freeley M, Park J, Yang KJ, Wange RL, Volkov Y, Kelleher D, Long A.
    Cell Signal; 2007 Dec 15; 19(12):2444-57. PubMed ID: 17826953
    [Abstract] [Full Text] [Related]

  • 9. PTEN and Other PtdIns(3,4,5)P3 Lipid Phosphatases in Breast Cancer.
    Csolle MP, Ooms LM, Papa A, Mitchell CA.
    Int J Mol Sci; 2020 Dec 02; 21(23):. PubMed ID: 33276499
    [Abstract] [Full Text] [Related]

  • 10. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
    Reed DE, Shokat KM.
    Mol Cancer Res; 2017 Jun 02; 15(6):765-775. PubMed ID: 28196852
    [Abstract] [Full Text] [Related]

  • 11. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, Gutkind JS, Li W.
    Oncogene; 2002 Aug 08; 21(34):5289-300. PubMed ID: 12149650
    [Abstract] [Full Text] [Related]

  • 12. PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity.
    Ma K, Cheung SM, Marshall AJ, Duronio V.
    Cell Signal; 2008 Apr 08; 20(4):684-94. PubMed ID: 18249092
    [Abstract] [Full Text] [Related]

  • 13. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S.
    Int J Cancer; 2007 Oct 01; 121(7):1424-32. PubMed ID: 17551921
    [Abstract] [Full Text] [Related]

  • 14. Impact of lipid phosphatases SHIP2 and PTEN on the time- and Akt-isoform-specific amelioration of TNF-alpha-induced insulin resistance in 3T3-L1 adipocytes.
    Ikubo M, Wada T, Fukui K, Ishiki M, Ishihara H, Asano T, Tsuneki H, Sasaoka T.
    Am J Physiol Endocrinol Metab; 2009 Jan 01; 296(1):E157-64. PubMed ID: 19001549
    [Abstract] [Full Text] [Related]

  • 15. Abnormal elevated PTEN expression in the mouse antrum of a model of GIST Kit(K641E/K641E).
    Deneubourg L, Ralea S, Gromova P, Parsons R, Vanderwinden JM, Erneux C.
    Cell Signal; 2011 Nov 01; 23(11):1857-68. PubMed ID: 21757001
    [Abstract] [Full Text] [Related]

  • 16. PTEN and SHIP2 regulates PI3K/Akt pathway through focal adhesion kinase.
    Gupta A, Dey CS.
    Mol Cell Endocrinol; 2009 Oct 15; 309(1-2):55-62. PubMed ID: 19501627
    [Abstract] [Full Text] [Related]

  • 17. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes.
    Sasaoka T, Wada T, Fukui K, Murakami S, Ishihara H, Suzuki R, Tobe K, Kadowaki T, Kobayashi M.
    J Biol Chem; 2004 Apr 09; 279(15):14835-43. PubMed ID: 14744864
    [Abstract] [Full Text] [Related]

  • 18. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X, Powelka AM, Soriano NA, Czech MP, Guilherme A.
    J Biol Chem; 2005 Jun 10; 280(23):22523-9. PubMed ID: 15824124
    [Abstract] [Full Text] [Related]

  • 19. Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells.
    Matsumoto J, Kaneda M, Tada M, Hamada J, Okushiba S, Kondo S, Katoh H, Moriuchi T.
    Jpn J Cancer Res; 2002 Dec 10; 93(12):1317-26. PubMed ID: 12495471
    [Abstract] [Full Text] [Related]

  • 20. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.
    Nakamura JL, Karlsson A, Arvold ND, Gottschalk AR, Pieper RO, Stokoe D, Haas-Kogan DA.
    J Neurooncol; 2005 Feb 10; 71(3):215-22. PubMed ID: 15735908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.